bioRxivPharmacology & ToxicologyPreprint
Evaluating the Immunological cross-reactivity of Indian polyvalent antivenoms towards the venom of Hypnale hypnale (hump-nosed pit viper) from the Western Ghats
M. Vanuopadath, D. Raveendran, B. Gopalakrishnan Nair, S. Sadasivan Nair
Abstract
Hypnale hypnale (hump-nosed pit viper) is a venomous pit viper species found in the Western Ghats of India and Sri Lanka. Due to the severe life-threatening envenomation effects induced by its venom components, Hypnale hypnale has been classified under category 1 of medically important snake species by the World Health Organization. Since there are no specific antivenoms available to combat its envenomation in India, the only option available is to administer Indian polyvalent antivenoms. However, the cross-neutralization potential of the commercially available polyvalent antivenoms on Indian Hypnale hypnale venom has not been explored so far. In the current study, in vitro immunological cross-reactivity of Hypnale hypnale venom towards various Indian polyvalent antivenoms were assessed using end point titration ELISA and Western blotting. A three to four-fold increase in EC50 values were obtained for Hypnale hypnale venom towards all the antivenoms tested. Observation of minimal binding specificities towards low and high molecular mass venom proteins are suggestive of the fact that commercially available polyvalent antivenoms failed to detect and bind to the antigenic epitopes of considerable number of proteins present in Hypnale hypnale venom. This highlights the importance of including Hypnale hypnale venom in the immunization mixture while raising antivenoms.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Venomics and antivenomics of Indian spectacled cobra (Naja naja) from the Western Ghats
M. Vanuopadath, D. Raveendran, … S. Sadasivan Nair·bioRxiv·Feb 15, 2021
- Purification and molecular characterization of phospholipase, antigen 5 and hyaluronidases from the venom of the Asian hornet (Vespa velutina)
R. I. MONSALVE, R. GUTIERREZ, … M. LOMBARDERO·bioRxiv·Nov 12, 2019
- Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: results of preclinical efficacy testing
S. K. Menzies, T. Litschka-Koen, … R. A. Harrison·bioRxiv·May 16, 2022
- Exploring the utility of recombinantly expressed snake venom serine protease toxins as immunogens for generating experimental snakebite antivenoms
N. Alomran, P. Blundell, … N. R. Casewell·bioRxiv·May 7, 2022
- Natures Antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms
Sean B. Carroll, Fiona P. Ukken, … Elda Eliza Sanchez·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 29, 2026
- A combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite
L.-O. Albulescu, C. Xie, … N. R. Casewell·bioRxiv·May 13, 2020